Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Multiple Sclerosis

Free Subscription Articles published in Arch Neurol Retrieve available abstracts of 63 articles: HTML format Text format

Single Articles

January 2012
1. POOL V , Gordon DM, Decker M
   Methodological issues with the risk of relapse study in patients with multiple sclerosis after yellow Fever vaccination.
   Arch Neurol. 2012;69:144.
   PubMed     Text format     Related articles   
   
   
   
   
2. MARCUS JF , Shalev SM, Harris CA, Goodin DS, et al
   Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.
   Arch Neurol. 2012;69:129-32.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. CARAMANOS Z , Francis SJ, Narayanan S, Lapierre Y, et al
   Large, nonplateauing relationship between clinical disability and cerebral white matter lesion load in patients with multiple sclerosis.
   Arch Neurol. 2012;69:89-95.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. CHERIYAN J , Kim S, Wolansky LJ, Cook SD, et al
   Impact of inflammation on brain volume in multiple sclerosis.
   Arch Neurol. 2012;69:82-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. GORMAN MP , Tillema JM, Ciliax AM, Guttmann CR, et al
   Daclizumab use in patients with pediatric multiple sclerosis.
   Arch Neurol. 2012;69:78-81.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
6. FILIPPI M , Rocca MA, De Stefano N, Enzinger C, et al
   Magnetic resonance techniques in multiple sclerosis: the present and the future.
   Arch Neurol. 2011;68:1514-20.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. WILLIAMS MA , Venkatesan A
   No endovascular innovation without evaluation in chronic cerebrospinal venous insufficiency: a call for the IDEAL model.
   Arch Neurol. 2011;68:1510-2.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
8. TUR C , Montalban X, Tintore M, Nos C, et al
   Interferon Beta-1b for the Treatment of Primary Progressive Multiple Sclerosis: Five-Year Clinical Trial Follow-up.
   Arch Neurol. 2011;68:1421-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. CHAN KH , Tse CT, Chung CP, Lee RL, et al
   Brain involvement in neuromyelitis optica spectrum disorders.
   Arch Neurol. 2011;68:1432-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SAURE C , Warnke C, Zohren F, Schroeder T, et al
    Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors.
    Arch Neurol. 2011;68:1428-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KIM SH , Kim W, Li XF, Jung IJ, et al
    Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years.
    Arch Neurol. 2011;68:1412-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
12. KINKEL RP , Dontchev M, Kollman C, Skaramagas TT, et al
    Association Between Immediate Initiation of Intramuscular Interferon Beta-1a at the Time of a Clinically Isolated Syndrome and Long-term Outcomes: A 10-Year Follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Ne
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
13. QIAN P , Cross AH, Naismith RT
    Lack of response to monoclonal antibody therapy in neuromyelitis optica.
    Arch Neurol. 2011;68:1207-9.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
14. MARDER E , Gupta P, Greenberg BM, Frohman EM, et al
    No Cerebral or Cervical Venous Insufficiency in US Veterans With Multiple Sclerosis.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. VAKNIN-DEMBINSKY A , Abramsky O, Petrou P, Ben-Hur T, et al
    Myasthenia Gravis-Associated Neuromyelitis Optica-Like Disease: An Immunological Link Between the Central Nervous System and Muscle?
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. KITLEY JL , Leite MI, Matthews LA, Palace J, et al
    Use of mitoxantrone in neuromyelitis optica.
    Arch Neurol. 2011;68:1086.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
17. BAGERT BA , Marder E, Stuve O
    Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KARACOSTAS D , Hadjigeorgiou G, Ioannidis P, Milonas I, et al
    How safe could intrathecal transplantation of mesenchymal stem cells be considered in multiple sclerosis?
    Arch Neurol. 2011;68:955.
    PubMed     Text format     Related articles   
    
    
    
    
19. COLLONGUES N , Cabre P, Marignier R, Zephir H, et al
    A benign form of neuromyelitis optica: does it exist?
    Arch Neurol. 2011;68:918-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. UZAWA A , Mori M, Masuda S, Kuwabara S, et al
    Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica.
    Arch Neurol. 2011;68:913-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MATIELLO M , Pittock SJ, Porrata L, Weinshenker BG, et al
    Failure of autologous hematopoietic stem cell transplantation to prevent relapse of neuromyelitis optica.
    Arch Neurol. 2011;68:953-5.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
22. FAREZ MF , Correale J
    Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
23. BUNYAN RF , Popescu BF, Carter JL, Caselli RJ, et al
    Childhood-onset multiple sclerosis with progressive dementia and pathological cortical demyelination.
    Arch Neurol. 2011;68:525-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. BUCK D , Cepok S, Hoffmann S, Grummel V, et al
    Influence of the HLA-DRB1 Genotype on Antibody Development to Interferon Beta in Multiple Sclerosis.
    Arch Neurol. 2011;68:480-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. RAMAGOPALAN SV , Meier UC, Conacher M, Ebers GC, et al
    Role of the HLA System in the Association Between Multiple Sclerosis and Infectious Mononucleosis.
    Arch Neurol. 2011;68:469-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. CREE BA , Stuart WH, Tornatore CS, Jeffery DR, et al
    Efficacy of Natalizumab Therapy in Patients of African Descent With Relapsing Multiple Sclerosis: Analysis of AFFIRM and SENTINEL Data.
    Arch Neurol. 2011;68:464-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. COYLE PK
    Pediatric multiple sclerosis: just like their elders?
    Arch Neurol. 2011;68:419-21.
    PubMed     Text format     Related articles   
    
    
    
    
28. ALMEKHLAFI MA , Clark AW, Lucchinetti CF, Zhang Y, et al
    Neuromyelitis optica with extensive active brain involvement: an autopsy study.
    Arch Neurol. 2011;68:508-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. KIM SH , Kim W, Park MS, Sohn EH, et al
    Efficacy and safety of mitoxantrone in patients with highly relapsing neuromyelitis optica.
    Arch Neurol. 2011;68:473-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
30. GILLI F , Navone ND, Perga S, Marnetto F, et al
    Loss of Braking Signals During Inflammation: A Factor Affecting the Development and Disease Course of Multiple Sclerosis.
    Arch Neurol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
31. STUVE O , Wang J, Chan A, Hemmer B, et al
    No association between genetic polymorphism at codon 129 of the prion protein gene and primary progressive multiple sclerosis.
    Arch Neurol. 2011;68:264-5.
    PubMed     Text format     Related articles   
    
    
    
    
32. JONES DT , Mateen FJ, Lucchinetti CF, Jack CR Jr, et al
    Default mode network disruption secondary to a lesion in the anterior thalamus.
    Arch Neurol. 2011;68:242-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
33. YEH EA , Waubant E, Krupp LB, Ness J, et al
    Multiple Sclerosis Therapies in Pediatric Patients With Refractory Multiple Sclerosis.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. JOHNSON TA , Lapierre Y, Bar-Or A, Antel JP, et al
    Distinct Properties of Circulating CD8+ T Cells in FTY720-Treated Patients With Multiple Sclerosis.
    Arch Neurol. 2010;67:1449-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
35. LANGER-GOULD A , Huang S, Van Den Eeden SK, Gupta R, et al
    Vitamin D, Pregnancy, Breastfeeding, and Postpartum Multiple Sclerosis Relapses.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. IORIO R , Plantone D, Frisullo G, Nociti V, et al
    Focal hyperhidrosis in tumefactive multiple sclerosis.
    Arch Neurol. 2010;67:1407-8.
    PubMed     Text format     Related articles   
    
    
    
    
37. KLAWITER EC , Benzinger T, Roy A, Naismith RT, et al
    Spinal cord ring enhancement in multiple sclerosis.
    Arch Neurol. 2010;67:1395-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
38. MIRAVALLE A , Jensen R, Kinkel RP
    Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. KARUSSIS D , Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, et al
    Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.
    Arch Neurol. 2010;67:1187-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. KALLURI SR , Illes Z, Srivastava R, Cree B, et al
    Quantification and functional characterization of antibodies to native aquaporin 4 in neuromyelitis optica.
    Arch Neurol. 2010;67:1201-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
41. ECHANIZ-LAGUNA A , Chassagne M, de Seze J, Mohr M, et al
    POLG1 Variations Presenting as Multiple Sclerosis.
    Arch Neurol. 2010;67:1140-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. KLAWITER EC , Piccio L, Lyons JA, Mikesell R, et al
    Elevated intrathecal myelin oligodendrocyte glycoprotein antibodies in multiple sclerosis.
    Arch Neurol. 2010;67:1102-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. KHOURY SJ , Healy BC, Kivisakk P, Viglietta V, et al
    A Randomized Controlled Double-Masked Trial of Albuterol Add-on Therapy in Patients With Multiple Sclerosis.
    Arch Neurol. 2010;67:1055-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. PACHECO MF , Jacobe H, Eagar TN, Stuve O, et al
    Reversible alopecia associated with glatiramer acetate.
    Arch Neurol. 2010;67:1154.
    PubMed     Text format     Related articles   
    
    
    
    
45. BICHUETTI DB , Lobato de Oliveira EM, Oliveira DM, Amorin de Souza N, et al
    Neuromyelitis optica treatment: analysis of 36 patients.
    Arch Neurol. 2010;67:1131-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. SOMINANDA A , Lundkvist M, Fogdell-Hahn A, Hemmer B, et al
    Inhibition of endogenous interferon beta by neutralizing antibodies against recombinant interferon beta.
    Arch Neurol. 2010;67:1095-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
47. KHANIFAR AA , Parlitsis GJ, Gauthier SA, Kiss S, et al
    Evaluating retinal abnormalities in patients with multiple sclerosis.
    Arch Neurol. 2010;67:1035.
    PubMed     Text format     Related articles   
    
    
    
    
48. RAMAGOPALAN SV , Hanwell HE, Giovannoni G, Knappskog PM, et al
    Vitamin D-Dependent Rickets, HLA-DRB1, and the Risk of Multiple Sclerosis.
    Arch Neurol. 2010;67:1034-5.
    PubMed     Text format     Related articles   
    
    
    
    
49. PALACE J , Leite MI, Nairne A, Vincent A, et al
    Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
    Arch Neurol. 2010;67:1016-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
50. SCHRODER A , Lee DH, Hellwig K, Lukas C, et al
    Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. RUDICK RA , Lee JC, Cutter GR, Miller DM, et al
    Disability Progression in a Clinical Trial of Relapsing-Remitting Multiple Sclerosis: Eight-Year Follow-up.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. STUVE O , Kieseier BC, Hemmer B, Hartung HP, et al
    Translational Research in Neurology and Neuroscience 2010: Multiple Sclerosis.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. PITT D , Boster A, Pei W, Wohleb E, et al
    Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging.
    Arch Neurol. 2010;67:812-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
54. LU JQ , Joseph JT, Nash RA, Storek J, et al
    Neuroinflammation and demyelination in multiple sclerosis after allogeneic hematopoietic stem cell transplantation.
    Arch Neurol. 2010;67:716-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. PICCIO L , Naismith RT, Trinkaus K, Klein RS, et al
    Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.
    Arch Neurol. 2010;67:707-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. PELLKOFER HL , Hohlfeld R, Kuempfel T
    Thirty-one episodes of myelitis and optic neuritis in a woman with neuromyelitis optica and systemic lupus erythematosus.
    Arch Neurol. 2010;67:779-80.
    PubMed     Text format     Related articles   
    
    
    
    
57. GAJOFATTO A , Monaco S, Fiorini M, Zanusso G, et al
    Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases.
    Arch Neurol. 2010;67:724-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
58. PELLICANO C , Gallo A, Li X, Ikonomidou VN, et al
    Relationship of cortical atrophy to fatigue in patients with multiple sclerosis.
    Arch Neurol. 2010;67:447-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. PHILLIPS JT
    Interferon neutralizing antibodies in multiple sclerosis: a new perspective.
    Arch Neurol. 2010;67:386-7.
    PubMed     Text format     Related articles   
    
    
    
    February 2010
60. VAN DER VOORT LF , Gilli F, Bertolotto A, Knol DL, et al
    Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis.
    Arch Neurol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. LEHMANN HC , Jangouk P, Kierysch EK, Meyer Zu Horste G, et al
    Autoantibody-mediated dysfunction of sympathetic neurons in guillain-barre syndrome.
    Arch Neurol. 2010;67:203-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
62. LANGER-GOULD A , Gupta R, Huang S, Hagan A, et al
    Interferon-gamma-producing T cells, pregnancy, and postpartum relapses of multiple sclerosis.
    Arch Neurol. 2010;67:51-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2009
63. WRIGHT BR , Warrington AE, Edberg DE, Rodriguez M, et al
    Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies.
    Arch Neurol. 2009;66:1456-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.    Design: